Telemedicine-driven rehabilitation in interstitial lung diseases: a narrative review [0.03%]
基于远程医疗的间质性肺病康复：综述
Sanghoon Park,Sue In Choi,Eun Joo Lee
Sanghoon Park
Introduction: Telemedicine is defined as the delivery of healthcare from a distance using electronic information and communication technology. Patients with interstitial lung disease (ILD) were among the early recipients ...
From ideal respiratory health to chronic lung disease: indicators of impaired respiratory health [0.03%]
从理想呼吸健康到慢性肺病：呼吸系统亚临床损伤的指标研究
Kavitha C Selvan,Joseph I Bailey,Ravi Kalhan
Kavitha C Selvan
Introduction: Ideal respiratory health and chronic respiratory disease exist on a continuum. Between these two extremes lies an intermediate state of impaired respiratory health, characterized by clinical phenotypes that ...
Prophylactic antibiotics in chronic pediatric lung disease: balancing benefit, resistance, and future care models [0.03%]
慢性儿科肺疾病的预防性抗生素治疗：平衡疗效、耐药性和未来治疗模式
Isaac Martin,Valerie Waters
Isaac Martin
Introduction: Children with chronic suppurative or inflammatory lung diseases, including cystic fibrosis (CF), non-CF bronchiectasis (NCFB), chronic suppurative lung disease (CSLD), and primary ciliary dyskinesia (PCD), e...
When cancer treatment affects the lungs: a clinical overview on pulmonary toxicity induced by new cancer drugs [0.03%]
抗癌治疗引起的肺毒性：新药所致肺毒性的临床概述
Dimitrios Komninos,Emmanouil Psarros,Eva Theochari et al.
Dimitrios Komninos et al.
Introduction: Novel targeted therapies and immune checkpoint inhibitors have transformed the therapeutic landscape of lung cancer, significantly improving survival outcomes. However, these new therapeutic agents are accom...
An overview of the importance of allied healthcare for patients with COPD [0.03%]
慢性阻塞性肺疾病患者康复相关医疗保健的重要作用概述
Sarah Houben-Wilke,Anouk W Vaes,Mara Cuijpers et al.
Sarah Houben-Wilke et al.
Introduction: Despite optimal pharmacological treatment, patients with COPD often experience symptoms and report physical, mental, and/or social limitations. This underlines the need for additional, non-pharmacological in...
The double threat: bacterial and fungal co-/superinfection in viral pneumonia [0.03%]
病毒性肺炎的双重威胁：细菌和真菌共感染或继发感染
Arsah Asis,Alejandro Rodríguez,Luis Felipe Reyes et al.
Arsah Asis et al.
Introduction: Respiratory viral pneumonias are a leading cause of severe respiratory failure and intensive care unit (ICU) admission worldwide. Although viral infection itself drives significant morbidity and mortality, s...
Airway clearance techniques - a proposed classification based on definitions? [0.03%]
基于定义的气道清除技术分类提案
Gregory Reychler,Nicolas Audag,Guillaume Prieur et al.
Gregory Reychler et al.
Introduction: Airway clearance techniques (ACT) are a longstanding modality of treatment in many chronic respiratory diseases. Their aims are to counteract airway obstruction by mobilizing airway secretions and/or by limi...
Aymen Jmai,Sandhya Matthes,Winfried Randerath
Aymen Jmai
Introduction: Central sleep apnea (CSA) affects up to one-third of patients with heart failure (HF) and is linked to sympathetic activation, arrhythmias, impaired quality of life, and worse prognosis. Understanding epidem...
Impact of anxiety, depression, fatigue and social isolation in patients with bronchiectasis [0.03%]
焦虑、抑郁、疲劳和社交孤立在支气管扩张症患者中的影响
Abebaw Mengistu Yohannes,Pooja Arora,George Marty Solomon
Abebaw Mengistu Yohannes
Biomarkers for the diagnosis and phenotyping of acute chest syndrome in patients with sickle cell disease [0.03%]
sickle细胞病患者急性胸部综合症诊断和表型的生物标志物
Maria Srour,Dylan Landis,Jenny Kim et al.
Maria Srour et al.
Introduction: Acute Chest Syndrome (ACS) is a serious and often fatal complication of Sickle Cell Disease (SCD). In the absence of specific biomarkers that indicate the development of ACS, diagnosis can be nebulous and di...